New hope for ruptured liver cancer: drug combo aims to prevent return
NCT ID NCT07331883
First seen Jan 12, 2026 · Last updated May 18, 2026 · Updated 19 times
Summary
This study tests whether a combination of two drugs (sintilimab and bevacizumab biosimilar) can help prevent liver cancer from coming back after surgery in people whose tumor had ruptured. About 35 adults with this high-risk condition will receive the treatment. The goal is to see if this approach is safe and improves how long patients live without the cancer returning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huashan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200031, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, 200025, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sanming First Hospital
NOT_YET_RECRUITINGSanming, Fujian, 365000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Third Bethune Hospital of Jilin University
RECRUITINGChangchun, Jilin, 130033, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.